Last reviewed · How we verify
Experimental: essential oils and ELA — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Experimental: essential oils and ELA (Experimental: essential oils and ELA) — University of Oslo. Essential oils combined with ELA (likely a proprietary extract or formulation) work through antimicrobial and anti-inflammatory properties to address unspecified therapeutic targets.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Experimental: essential oils and ELA TARGET | Experimental: essential oils and ELA | University of Oslo | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Experimental: essential oils and ELA CI watch — RSS
- Experimental: essential oils and ELA CI watch — Atom
- Experimental: essential oils and ELA CI watch — JSON
- Experimental: essential oils and ELA alone — RSS
Cite this brief
Drug Landscape (2026). Experimental: essential oils and ELA — Competitive Intelligence Brief. https://druglandscape.com/ci/experimental-essential-oils-and-ela. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab